» Articles » PMID: 32757186

Vertical Transmission of SARS-CoV-2 (COVID-19): Are Hypotheses More Than Evidences?

Overview
Journal Am J Perinatol
Date 2020 Aug 7
PMID 32757186
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

In spite of the increasing, accumulating knowledge on the novel pandemic coronavirus severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), questions on the coronavirus disease-2019 (COVID-19) infection transmission from mothers to fetuses or neonates during pregnancy and peripartum period remain pending and have not been addressed so far. SARS-CoV-2, a RNA single-stranded virus, has been detected in the amniotic fluid, in the cord blood and in the placentas of the infected women. In the light of these findings, the theoretical risk of intrauterine infection for fetuses, or of peripartum infection occurring during delivery for neonates, has a biological plausibility. The extent of this putative risk might, however, vary during the different stages of pregnancy, owing to several variables (physiological modifications of the placenta, virus receptors' expression, or delivery route). This brief review provides an overview of the current evidence in this area. Further data, based on national and international multicenter registries, are needed not only to clearly assess the extent of the risk for vertical transmission, but also to ultimately establish solid guidelines and consistent recommendations. KEY POINTS: · Questions on the COVID-19 infection transmission from mothers to fetuses or neonates during pregnancy and peripartum period remain pending so far.. · The theoretical risk of intrauterine infection for fetuses, or of neonatal infection during delivery for neonates, has a biological plausibility.. · A caution is recommended in the interpretation of clinical and laboratory data in neonates..

Citing Articles

Association of SARS-CoV-2 Infection during pregnancy with placental weight and histopathologic lesions.

Theiler R, Warring S, Young M, Santos J, Branda M, Quinton R Placenta. 2024; 159():180-186.

PMID: 39736235 PMC: 11745490. DOI: 10.1016/j.placenta.2024.12.017.


Neutralizing antibodies in milk and blood of lactating women vaccinated for SARS-CoV-2: a systematic review.

Vieira I, Rocha F, Vilarim M, Rebelo F, Marano D Rev Paul Pediatr. 2024; 43:e2023210.

PMID: 39258663 PMC: 11382815. DOI: 10.1590/1984-0462/2025/43/2023210.


Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women.

Vercoutere A, Zina M, Telis M, Goffard J, Boulvain M, de Doncker L BMC Infect Dis. 2024; 24(1):509.

PMID: 38773493 PMC: 11110414. DOI: 10.1186/s12879-024-09399-6.


Associations of SARS-CoV-2 antibodies with birth outcomes: Results from three urban birth cohorts in the NIH environmental influences on child health outcomes program.

Trasande L, Comstock S, Herbstman J, Margolis A, Alcedo G, Afanasyeva Y PLoS One. 2023; 18(11):e0293652.

PMID: 37992059 PMC: 10664934. DOI: 10.1371/journal.pone.0293652.


Physical activity in lactating women influences SARS-CoV-2-specific antibodies in human milk.

Juncker H, van Doesburg M, de Groot C, Pajkrt D, Korosi A, van Gils M Heliyon. 2023; 9(8):e19218.

PMID: 37654447 PMC: 10466918. DOI: 10.1016/j.heliyon.2023.e19218.


References
1.
Tam P, Ly K, Kernich M, Spurrier N, Lawrence D, Gordon D . Detectable Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Human Breast Milk of a Mildly Symptomatic Patient With Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2020; 72(1):128-130. PMC: 7314245. DOI: 10.1093/cid/ciaa673. View

2.
Gross R, Conzelmann C, Muller J, Stenger S, Steinhart K, Kirchhoff F . Detection of SARS-CoV-2 in human breastmilk. Lancet. 2020; 395(10239):1757-1758. PMC: 7241971. DOI: 10.1016/S0140-6736(20)31181-8. View

3.
Liu W, Wang J, Li W, Zhou Z, Liu S, Rong Z . Clinical characteristics of 19 neonates born to mothers with COVID-19. Front Med. 2020; 14(2):193-198. PMC: 7152620. DOI: 10.1007/s11684-020-0772-y. View

4.
Setti L, Passarini F, de Gennaro G, Barbieri P, Perrone M, Borelli M . Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough. Int J Environ Res Public Health. 2020; 17(8). PMC: 7215485. DOI: 10.3390/ijerph17082932. View

5.
Alonso Diaz C, Lopez Maestro M, Moral Pumarega M, Flores Anton B, Pallas Alonso C . First case of neonatal infection due to COVID-19 in Spain. An Pediatr (Engl Ed). 2020; 92(4):237-238. PMC: 7195017. DOI: 10.1016/j.anpede.2020.03.002. View